|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0001792,
umls-concept:C0014025,
umls-concept:C0030705,
umls-concept:C0036043,
umls-concept:C0085580,
umls-concept:C0231491,
umls-concept:C0248719,
umls-concept:C0597357,
umls-concept:C1257890,
umls-concept:C1412113,
umls-concept:C1707455,
umls-concept:C2603343
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
1999-4-28
|
|
pubmed:abstractText |
To assess the antihypertensive efficacy and safety of the novel AT1 receptor antagonist, telmisartan, compared with that of enalapril in elderly patients with mild to moderate hypertension.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Angiotensin Receptor Antagonists,
http://linkedlifedata.com/resource/pubmed/chemical/Angiotensin-Converting Enzyme...,
http://linkedlifedata.com/resource/pubmed/chemical/Benzimidazoles,
http://linkedlifedata.com/resource/pubmed/chemical/Benzoates,
http://linkedlifedata.com/resource/pubmed/chemical/Diuretics,
http://linkedlifedata.com/resource/pubmed/chemical/Enalapril,
http://linkedlifedata.com/resource/pubmed/chemical/Hydrochlorothiazide,
http://linkedlifedata.com/resource/pubmed/chemical/Receptor, Angiotensin, Type 1,
http://linkedlifedata.com/resource/pubmed/chemical/Receptor, Angiotensin, Type 2,
http://linkedlifedata.com/resource/pubmed/chemical/Renin,
http://linkedlifedata.com/resource/pubmed/chemical/Sodium Chloride Symporter Inhibitors,
http://linkedlifedata.com/resource/pubmed/chemical/telmisartan
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
0263-6352
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
17
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
293-302
|
|
pubmed:dateRevised |
2010-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:10067800-Administration, Oral,
pubmed-meshheading:10067800-Aged,
pubmed-meshheading:10067800-Angiotensin Receptor Antagonists,
pubmed-meshheading:10067800-Angiotensin-Converting Enzyme Inhibitors,
pubmed-meshheading:10067800-Benzimidazoles,
pubmed-meshheading:10067800-Benzoates,
pubmed-meshheading:10067800-Blood Pressure,
pubmed-meshheading:10067800-Blood Pressure Monitoring, Ambulatory,
pubmed-meshheading:10067800-Diuretics,
pubmed-meshheading:10067800-Dose-Response Relationship, Drug,
pubmed-meshheading:10067800-Double-Blind Method,
pubmed-meshheading:10067800-Enalapril,
pubmed-meshheading:10067800-Female,
pubmed-meshheading:10067800-Follow-Up Studies,
pubmed-meshheading:10067800-Humans,
pubmed-meshheading:10067800-Hydrochlorothiazide,
pubmed-meshheading:10067800-Hypertension,
pubmed-meshheading:10067800-Male,
pubmed-meshheading:10067800-Quality of Life,
pubmed-meshheading:10067800-Receptor, Angiotensin, Type 1,
pubmed-meshheading:10067800-Receptor, Angiotensin, Type 2,
pubmed-meshheading:10067800-Renin,
pubmed-meshheading:10067800-Safety,
pubmed-meshheading:10067800-Sodium Chloride Symporter Inhibitors,
pubmed-meshheading:10067800-Supine Position,
pubmed-meshheading:10067800-Treatment Outcome
|
|
pubmed:year |
1999
|
|
pubmed:articleTitle |
Efficacy and safety of telmisartan, a selective AT1 receptor antagonist, compared with enalapril in elderly patients with primary hypertension. TEES Study Group.
|
|
pubmed:affiliation |
Department of Internal Medicine, University Hospital, Linköping, Sweden.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial,
Multicenter Study
|
